SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 17, 2026

MLYS

Mineralys Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago
Insider cluster: 2 insiders, $310K total
Actionable Insight • Neutral

The insider sales are routine and non-informative given the trivial dollar amount and pattern of exercise-and-sell. No bearish read-through. Monitor upcoming clinical trial readouts for MLYS's pipeline as the primary catalyst.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$24.63
T+0 close · Jun 17, 2026 · via day close
Latest settled
+17.54%
T+60 · $28.95
Vs SPY
+15.65%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 18 $24.63entry
  2. T+1 · 5mo ago +3.00%α +3.32% · $25.37
  3. T+5 · 5mo ago +6.94%α +8.61% · $26.34
  4. T+20 · 4mo ago +9.95%α +9.41% · $27.08
  5. T+60 · 2mo ago +17.54%α +15.65% · $28.95
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at Mineralys Therapeutics (MLYS) sold a combined $310K in open-market transactions over a 7-day window. The dollar amount is trivial relative to the $2.0B market cap (0.0155%), and the sales follow option exercises, indicating routine tax/vesting-related liquidity rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$310.0K
Insiders
2

Key Facts

  • CMO Rodman David Malcom sold 9,900 shares at $23.81 on June 15, 2026, for $235K
  • Director Daphne Karydas sold 3,000 shares at $25.00 on June 17, 2026, for $75K
  • Total open-market sales of $310K represent 0.0155% of MLYS's $2.0B market cap
  • Both sales were preceded by option exercises at nominal or low strike prices, consistent with tax withholding or diversification

Financial Impact

Total insider sales of $310K are immaterial at 0.0155% of market cap; no financial impact on the company.

insider selling

Risk Factors

  • No material risk identified from this cluster; the sales are liquidity-driven and not indicative of fundamental deterioration

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MLYS-1781745507906

Track record

35 reports on MLYS

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +20.97% at T+20 after the Jun 11, 2026 report. 5 of 10 went positive at some point.

Filters
  1. Nov 8, 20268d ago Press Release Bullish 6/10 Entry $15.81 Now $14.53 −8.10% settles Dec 8
  2. Nov 4, 202612d ago 8-K Neutral 4/10 Entry $15.24 Now $14.53 −4.66% settles Dec 4
  3. Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $15.99 Now $14.53 −9.13% settles Dec 2
  4. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $18.18 Now $14.53 −20.08% settles Nov 30
  5. Oct 28, 202619d ago Press Release Bullish 6/10 Entry $21.38 Now $14.53 −32.04% settles Nov 25
  6. Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 Now $14.53 −31.14% settles Nov 18
  7. Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 Now $14.53 −31.14% settles Nov 18
  8. Oct 19, 202628d ago 8-K Neutral 2/10 Entry $21.58 Now $14.53 −32.67% settles Nov 17
  9. Oct 13, 20264w ago 144 Neutral 3/10 Entry $20.76 to $16.16 Now $14.53 −30.01% ▼ −22.16% −20.89% vs SPY
  10. Sep 30, 20266w ago 144 Neutral 3/10 Entry $23.72 to $21.24 Now $14.53 −38.74% ▼ −10.46% −11.16% vs SPY
Showing 10 of 35

US Market Status

Market Closed · Opens in 8h 45m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 17, 2026